A unique aspect of AD is the heterogeneous clinical presentation, including diverse cutaneous cytokine profiles, which can include IFNγ, IL-4 + IL-13, IL-17A, and IL-22 [5,6,7,8]. This evidence concerns the gene IL17A and Alzheimer disease.